Centre Hospitalier de Colmar

corporate_fareorganization

Centre Hospitalier de Colmar

- Funding / Projects
  (7)

7 Projects, page 1 of 2

Etude multicentrique de phase III randomisée ouverte testant l’efficacité du gemtuzumab (MYLOTARG) en association avec la chimiothérapie intensive chez les patients de 18 à 60 ans atteints de leucémie aiguë myéloblastique avec cytogénétique intermédiaire. Randomized Open Phase III Trial Testing Efficacy of Gemtuzumab Ozogamycin (MYLOTARG) Associated to Intensive Chemotherapy for Patients Aged Between 18-60 Years and Presenting an Acute Myeloid Leukemia (AML) With Intermediate Risk
assignment_turned_inProjectPartners:Hôpital le Bocage, Centre Hospitalier de Colmar, CHU Nantes - Hôtel Dieu, Hôpital Jean Minjoz, Centre Hospitalier de Colmar +7 partners
Hôpital le Bocage,
Centre Hospitalier de Colmar,
CHU Nantes - Hôtel Dieu,
Hôpital Jean Minjoz,
Centre Hospitalier de Colmar,
Hôpital Morvan,
CHU Nantes - Hôtel Dieu,
Centre Hospitalier de la Côte Basque,
Centre Hospitalier du Pays d'Aix,
Centre Hospitalier du Pays d'Aix,
CHUG,
Hôpital Notre-Dame de Bon Secours
Funder: Institut National du Cancer Project Code: INCa-DGOS-2565
linkLink to
shareshareShare
uploaduploadDeposit
Select content type to embed
All Research products
arrow_drop_down
<script type="text/javascript">  </script>
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
more_vert
linkLink to
shareshareShare
uploaduploadDeposit
Select content type to embed
All Research products
arrow_drop_down
<script type="text/javascript">  </script>
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
Phase III study comparing post-operative conformal radiotherapy to no post operative radiotherapy in patients with completely resected non-small cell lung cancer (NSCLC) and mediastinal N2 involvement
assignment_turned_inProjectPartners:Hôpital Sainte Marguerite (Hôpitaux Sud), Institut Gustave Roussy, Centre Hospitalier de Colmar, Hôpital Sainte Marguerite (Hôpitaux Sud), Centre Antoine Lacassagne +4 partners
Hôpital Sainte Marguerite (Hôpitaux Sud),
Institut Gustave Roussy,
Centre Hospitalier de Colmar,
Hôpital Sainte Marguerite (Hôpitaux Sud),
Centre Antoine Lacassagne,
Centre Oscar Lambret,
Centre Hospitalier de Colmar,
Centre Eugène Marquis,
Hôpital Bretonneau
Funder: Institut National du Cancer Project Code: INCa-DGOS-5548
linkLink to
shareshareShare
uploaduploadDeposit
Select content type to embed
All Research products
arrow_drop_down
<script type="text/javascript">  </script>
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
more_vert
linkLink to
shareshareShare
uploaduploadDeposit
Select content type to embed
All Research products
arrow_drop_down
<script type="text/javascript">  </script>
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
Plateforme d'Alsace
assignment_turned_inProject2011 - 2012Partners:Centre Hospitalier de Colmar, Centre Hospitalier de Colmar, Hôpital Emile Muller, Centre Paul Strauss, CNRS UMR7104 - INSERM U964
Centre Hospitalier de Colmar,
Centre Hospitalier de Colmar,
Hôpital Emile Muller,
Centre Paul Strauss,
CNRS UMR7104 - INSERM U964
Funder: Institut National du Cancer Project Code: INCa-3625
linkLink to
shareshareShare
uploaduploadDeposit
Select content type to embed
All Research products
arrow_drop_down
<script type="text/javascript">  </script>
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
more_vert
linkLink to
shareshareShare
uploaduploadDeposit
Select content type to embed
All Research products
arrow_drop_down
<script type="text/javascript">  </script>
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
BLOCAGE-01: A phase III trial evaluating maintenance treatment versus observation in elderly patients suffering from primary central nervous system lymphoma in complete remission after high dose methotrexate based chemotherapy in first line
assignment_turned_inProjectPartners:Centre Hospitalier Universitaire de Rennes, Hôpital Côte de Nacre, ICM-VAL D'AURELLE, Hôpital Central, Groupe Hospitalier Pitié Salpétrière +25 partners
Centre Hospitalier Universitaire de Rennes,
Hôpital Côte de Nacre,
ICM-VAL D'AURELLE,
Hôpital Central,
Groupe Hospitalier Pitié Salpétrière,
CHU Marseille - Hôpital la Timone,
Hôpital Jean Minjoz,
Centre Léon Bérard,
CHU Marseille - Hôpital la Timone,
Centre Léon Bérard,
Institut Bergonié,
Délégation à la Recherche Clinique et à Iinnovation - CHRU de Brest,
Polyclinique de Courlancy,
CHUAP,
Centre Hospitalier Universitaire de Tours,
Hôpital René Huguenin - Institut Curie,
Hôpital le Bocage,
Centre Hospitalier de Colmar,
CHUAP,
Délégation à la Recherche Clinique et à Iinnovation - CHRU de Brest,
Centre Hospitalier de Colmar,
Centre Hospitalier Régional et Universitaire de Lille,
Hôpital Dupuytren,
CHUG,
Délégation à la Recherche et à lInnovation - CHU Angers,
Centre Henri Becquerel,
Délégation à la Recherche et à lInnovation - CHU Angers,
Hôpital Central,
Hôpital de Rangueil,
Centre Hospitalier Universitaire de Rennes
Funder: Institut National du Cancer Project Code: INCa-DGOS-7342
linkLink to
shareshareShare
uploaduploadDeposit
Select content type to embed
All Research products
arrow_drop_down
<script type="text/javascript">  </script>
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
more_vert
linkLink to
shareshareShare
uploaduploadDeposit
Select content type to embed
All Research products
arrow_drop_down
<script type="text/javascript">  </script>
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
A randomized phase III study of Velcade-Melphalan 200 conditioning regimen versus Melphalan 200 for frontline transplant eligible patients with multiple myeloma
assignment_turned_inProjectPartners:Centre Hospitalier Universitaire de Rennes, Centre Hospitalier Universitaire de Saint-Étienne, Hôpital Jean Minjoz, Hôpital le Bocage, CEA Fontenay-aux-Roses +30 partners
Centre Hospitalier Universitaire de Rennes,
Centre Hospitalier Universitaire de Saint-Étienne,
Hôpital Jean Minjoz,
Hôpital le Bocage,
CEA Fontenay-aux-Roses,
Centre Hospitalier de Colmar,
Centre Léon Bérard,
Centre Hospitalier René Dubos,
Hôpitaux de Brabois Adultes-Enfants,
Centre Hospitalier de Colmar,
Hôpital Dupuytren,
Hôpital Morvan,
Centre Hospitalier Victor Dupouy,
Centre Léon Bérard,
Hôpital Purpan,
Groupe Hospitalier Henri Mondor - Albert Chenevier,
Hôpital Bretonneau,
CHM,
Hôpital d'Instruction des Armées (HIA) Percy,
CHM,
Hôpital Claude Huriez,
Centre Hospitalier de la Côte Basque,
Hôpital Notre-Dame de Bon Secours,
Hôpital Saint-Louis,
Délégation à la Recherche et à lInnovation - CHU Angers,
Délégation à la Recherche et à lInnovation - CHU Angers,
Hôpital Saint-Louis,
Centre Hospitalier Universitaire de Rennes,
HUS,
Centre Hospitalier Universitaire de la Réunion,
Centre Hospitalier Victor Dupouy,
Hôpital Avicenne,
Centre Hospitalier Universitaire de Clermont-Ferrand,
Groupe Hospitalier Cochin,
Centre Hospitalier Universitaire de Clermont-Ferrand
Funder: Institut National du Cancer Project Code: INCa-DGOS-7292
linkLink to
shareshareShare
uploaduploadDeposit
Select content type to embed
All Research products
arrow_drop_down
<script type="text/javascript">  </script>
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
more_vert
linkLink to
shareshareShare
uploaduploadDeposit
Select content type to embed
All Research products
arrow_drop_down
<script type="text/javascript">  </script>
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu

chevron_left
1
2
chevron_right

Centre Hospitalier de Colmar

Centre Hospitalier de Colmar

7 Projects, page 1 of 2

Phase III study comparing post-operative conformal radiotherapy to no post operative radiotherapy in patients with completely resected non-small cell lung cancer (NSCLC) and mediastinal N2 involvement

Plateforme d'Alsace

BLOCAGE-01: A phase III trial evaluating maintenance treatment versus observation in elderly patients suffering from primary central nervous system lymphoma in complete remission after high dose methotrexate based chemotherapy in first line

A randomized phase III study of Velcade-Melphalan 200 conditioning regimen versus Melphalan 200 for frontline transplant eligible patients with multiple myeloma

Loading